In the present paper, we show for the first time that an increased SGK1 mRNA expression was significantly enhanced in high-grade astrocytoma and GBM from well-staged patients, when compared with normal brain tissue. The gene discussed is SGK1; the disease is astrocytoma (excluding glioblastoma).